Note*: This report requires 5-10 business days to complete.
DelveInsight’s Genital Herpes - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Genital Herpes forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Genital Herpes till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Genital Herpes market.
• Identifying patient populations in the global “Genital Herpesmarket to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Genital Herpes therapeutics in each of the markets covered.
• To understand the future market competition in the global Genital Herpes therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Genital Herpes for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Genital Herpes overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Genital Herpes Market
• Global Epidemiology of Genital Herpes Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Genital Herpes Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Genital Herpes (2013-2023)
• Table 7: Genital Herpes Global Market (USD Millions), (2013-2015)
• Table 8: Genital Herpes Global Market (USD Millions), (2016-2023)
• Table 9: Genital Herpes US Market (USD Millions), (2013-2015)
• Table 10: Genital Herpes US Market (USD Millions), (2016-2023)
• Table 11: Genital Herpes Germany Market (USD Millions), (2013-2015)
• Table 12: Genital Herpes Germany Market (USD Millions), (2016-2023)
• Table 13: Genital Herpes United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Genital Herpes United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Genital Herpes France Market (USD Millions), (2013-2015)
• Table 16: Genital Herpes France Market (USD Millions), (2016-2023)
• Table 17: Genital Herpes Italy Market (USD Millions), (2013-2015)
• Table 18: Genital Herpes Italy Market (USD Millions), (2016-2023)
• Table 19: Genital Herpes Spain Market (USD Millions), (2013-2015)
• Table 20: Genital Herpes Spain Market (USD Millions), (2016-2023)
• Table 21: Genital Herpes Japan Market (USD Millions), (2013-2015)
• Table 22: Genital Herpes Japan Market (USD Millions), (2016-2023)
• Table 23: Genital Herpes ROW Market (USD Millions), (2013-2015)
• Table 24: Genital Herpes ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Genital Herpes Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Genital Herpes (2013-2023)
• Figure 3: Genital Herpes Global Market (USD Millions), (2013-2015)
• Figure 4: Genital Herpes Global Market (USD Millions), (2016-2023)
• Figure 5: Genital Herpes US Market (USD Millions), (2013-2015)
• Figure 6: Genital Herpes US Market (USD Millions), (2016-2023)
• Figure 7: Genital Herpes Germany Market (USD Millions), (2013-2015)
• Figure 8: Genital Herpes Germany Market (USD Millions), (2016-2023)
• Figure 9: Genital Herpes United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Genital Herpes United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Genital Herpes France Market (USD Millions), (2013-2015)
• Figure 12: Genital Herpes France Market (USD Millions), (2016-2023)
• Figure 13: Genital Herpes Italy Market (USD Millions), (2013-2015)
• Figure 14: Genital Herpes Italy Market (USD Millions), (2016-2023)
• Figure 15: Genital Herpes Spain Market (USD Millions), (2013-2015)
• Figure 16: Genital Herpes Spain Market (USD Millions), (2016-2023)
• Figure 17: Genital Herpes Japan Market (USD Millions), (2013-2015)
• Figure 18: Genital Herpes Japan Market (USD Millions), (2015-2023)
• Figure 19: Genital Herpes ROW Market (USD Millions), (2013-2015)
• Figure 20: Genital Herpes ROW Market (USD Millions), (2016-2023)
• Admedus Ltd
• AiCuris GmbH & Co. KG
• AlphaVax Inc.
• Foamix Pharmaceuticals Ltd.
• Genocea Biosciences Inc.
• GenVec Inc.
• Immune Design Corp.
• Immunovaccine Inc.
• Mymetics Corporation
• NanoBio Corporation
• NanoViricides Inc.
• PaxVax
• Profectus BioSciences Inc.
